A team from Baylor College of Medicine and Texas Children's Cancer Center led the study, which tested chimeric antigen ...

Data presented at AACR demonstrates that the ability of the enveloped virotherapy to express IL15 superagonist specifically in the tumor microenvironment measurably increases the number of ...

The company reported a net loss attributable to common stockholders of $5.0 million, or $0.18 per share, for the three months ended March 31, 2025, compared to a net loss attributable to common ...